199 related articles for article (PubMed ID: 24591641)
1. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.
Stsiapanava A; Olsson U; Wan M; Kleinschmidt T; Rutishauser D; Zubarev RA; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4227-32. PubMed ID: 24591641
[TBL] [Abstract][Full Text] [Related]
2. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
3. Capturing LTA
Stsiapanava A; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9689-9694. PubMed ID: 28827365
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
Appiah-Kubi P; Soliman M
Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene A4 hydrolase, insights into the molecular evolution by homology modeling and mutational analysis of enzyme from Saccharomyces cerevisiae.
Tholander F; Kull F; Ohlson E; Shafqat J; Thunnissen MM; Haeggström JZ
J Biol Chem; 2005 Sep; 280(39):33477-86. PubMed ID: 16024909
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.
Mueller MJ; Wetterholm A; Blomster M; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8383-7. PubMed ID: 7667299
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378.
Mueller MJ; Blomster M; Oppermann UC; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5931-5. PubMed ID: 8650196
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A
Teder T; König S; Singh R; Samuelsson B; Werz O; Garscha U; Haeggström JZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108702
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
Thunnissen MM; Andersson B; Samuelsson B; Wong CH; Haeggström J
FASEB J; 2002 Oct; 16(12):1648-50. PubMed ID: 12207002
[TBL] [Abstract][Full Text] [Related]
11. The development of novel LTA
Low CM; Akthar S; Patel DF; Löser S; Wong CT; Jackson PL; Blalock JE; Hare SA; Lloyd CM; Snelgrove RJ
Sci Rep; 2017 Mar; 7():44449. PubMed ID: 28303931
[TBL] [Abstract][Full Text] [Related]
12. Effect of Modifier Structure on the Activation of Leukotriene A
Lee KH; Petruncio G; Shim A; Burdick M; Zhang Z; Shim YM; Noble SM; Paige M
J Med Chem; 2019 Dec; 62(23):10605-10616. PubMed ID: 31751136
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene A4 hydrolase: selective abrogation of leukotriene B4 formation by mutation of aspartic acid 375.
Rudberg PC; Tholander F; Thunnissen MM; Samuelsson B; Haeggstrom JZ
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4215-20. PubMed ID: 11917124
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase.
Blomster M; Wetterholm A; Mueller MJ; Haeggström JZ
Eur J Biochem; 1995 Aug; 231(3):528-34. PubMed ID: 7649151
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1-7.
Nissen JB; Iversen L; Kragballe K
Br J Dermatol; 1995 Nov; 133(5):742-9. PubMed ID: 8555027
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase B is structurally related to leukotriene-A4 hydrolase but is not a bifunctional enzyme with epoxide hydrolase activity.
Fukasawa KM; Fukasawa K; Harada M; Hirose J; Izumi T; Shimizu T
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):497-502. PubMed ID: 10215585
[TBL] [Abstract][Full Text] [Related]
17. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.
Liang AM; Claret E; Ouled-Diaf J; Jean A; Vogel D; Light DR; Jones SW; Guilford WJ; Parkinson JF; Snider RM
J Biomol Screen; 2007 Jun; 12(4):536-45. PubMed ID: 17384330
[TBL] [Abstract][Full Text] [Related]
18. Product formation controlled by substrate dynamics in leukotriene A4 hydrolase.
Stsiapanava A; Tholander F; Kumar RB; Qureshi AA; Niegowski D; Hasan M; Thunnissen M; Haeggström JZ; Rinaldo-Matthis A
Biochim Biophys Acta; 2014 Feb; 1844(2):439-46. PubMed ID: 24333438
[TBL] [Abstract][Full Text] [Related]
19. Saccharomyces cerevisiae leukotriene A4 hydrolase: formation of leukotriene B4 and identification of catalytic residues.
Kull F; Ohlson E; Lind B; Haeggström JZ
Biochemistry; 2001 Oct; 40(42):12695-703. PubMed ID: 11601994
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of diaryl ether modulators of the leukotriene A
Petruncio G; Lee KH; Girgis M; Shellnutt Z; Beaulac Z; Xiang J; Lee SH; Peng X; Burdick M; Noble SM; Shim YM; Paige M
Eur J Med Chem; 2024 Jun; 272():116459. PubMed ID: 38704942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
